Question 1

What is the ESG rating for AMGN?

Accepted Answer

Amgen Inc. has the following ESG ratings: MSCI ESG Rating: AA, Sustainalytics ESG Risk: 22.0 (Medium Risk), ESG Enterprise Score: 81/100 (Refinitiv).

Question 2

What are the main strengths of investing in AMGN?

Accepted Answer

The main strengths of investing in Amgen Inc. include: Aggressive carbon neutrality target by 2027 with 40% water reduction goals, $1.25 billion green bond for environmental projects and renewable energy, Strong patient assistance programs and 52% minority, 47% female workforce.

Question 3

What are the potential drawbacks of investing in AMGN?

Accepted Answer

Potential drawbacks of investing in Amgen Inc. include: Drug pricing scrutiny for expensive biologics affecting healthcare access, Biosimilar competition creating revenue headwinds for key products, Regulatory risks inherent to pharmaceutical industry operations.

Question 4

What are the key financial metrics for AMGN?

Accepted Answer

Key financial metrics for Amgen Inc. include: Market Cap: $1.12 billion, Current Price: $45.16, Dividend Yield: 3.43%.

Amgen Inc.

Detailed View

AMGN

ESG Ratings